Al Khzem A, Gomaa M, Alturki M, Tawfeeq N, Sarafroz M, Alonaizi S
Int J Mol Sci. 2024; 25(22).
PMID: 39596504
PMC: 11595001.
DOI: 10.3390/ijms252212441.
Azalim-Neto P, Noel F, Silva S, Villar J, Barbosa L, ODoherty G
Mol Pharmacol. 2024; 106(5):225-239.
PMID: 39187390
PMC: 11493336.
DOI: 10.1124/molpharm.124.000934.
Djerdjouri A, Abbad M, Boumrah Y, Malik S, Makhzoum A, Lakhdar K
3 Biotech. 2024; 14(9):199.
PMID: 39144068
PMC: 11319682.
DOI: 10.1007/s13205-024-04035-1.
Zhan Y, Wang R, Huang C, Xu X, Xiao X, Wu L
Oncol Rep. 2024; 52(2).
PMID: 38940341
PMC: 11229393.
DOI: 10.3892/or.2024.8762.
Chakraborty S, Wei D, Tran M, Lang F, Newman R, Yang P
Neoplasia. 2024; 54:101008.
PMID: 38823209
PMC: 11177059.
DOI: 10.1016/j.neo.2024.101008.
Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anti-cancer effect.
Katoh M, Fujii T, Tabuchi Y, Shimizu T, Sakai H
J Physiol Sci. 2024; 74(1):23.
PMID: 38561668
PMC: 10985892.
DOI: 10.1186/s12576-024-00914-7.
Cardiac glycosides inhibit early and late vaccinia virus protein expression.
Samolej J, White I, Strang B, Mercer J
J Gen Virol. 2024; 105(3).
PMID: 38546099
PMC: 10995631.
DOI: 10.1099/jgv.0.001971.
Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy.
Miao K, Liu W, Xu J, Qian Z, Zhang Q
Front Immunol. 2023; 14:1277243.
PMID: 38035069
PMC: 10684919.
DOI: 10.3389/fimmu.2023.1277243.
Transcriptome Profiling of Cardiac Glycoside Treatment Reveals EGR1 and Downstream Proteins of MAPK/ERK Signaling Pathway in Human Breast Cancer Cells.
Pavithran H, Kumavath R, Ghosh P
Int J Mol Sci. 2023; 24(21).
PMID: 37958905
PMC: 10647710.
DOI: 10.3390/ijms242115922.
Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3).
Jayaraman S, Natarajan S, Veeraraghavan V, Jasmine S
J Oral Biol Craniofac Res. 2023; 13(6):704-713.
PMID: 37731845
PMC: 10507650.
DOI: 10.1016/j.jobcr.2023.09.002.
In Vitro Study of the Multimodal Effect of Na/K ATPase Blocker Ouabain on the Tumor Microenvironment and Malignant Cells.
Harich O, Gavriliuc O, Ordodi V, Tirziu A, Paunescu V, Panaitescu C
Biomedicines. 2023; 11(8).
PMID: 37626702
PMC: 10452365.
DOI: 10.3390/biomedicines11082205.
The mechanistic role of cardiac glycosides in DNA damage response and repair signaling.
Ainembabazi D, Zhang Y, Turchi J
Cell Mol Life Sci. 2023; 80(9):250.
PMID: 37584722
PMC: 10432338.
DOI: 10.1007/s00018-023-04910-9.
The potential of fungi in the bioremediation of pharmaceutically active compounds: a comprehensive review.
Amobonye A, Aruwa C, Aransiola S, Omame J, Alabi T, Lalung J
Front Microbiol. 2023; 14:1207792.
PMID: 37502403
PMC: 10369004.
DOI: 10.3389/fmicb.2023.1207792.
Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation.
Fan Z, Wang S, Xu C, Yang J, Cui B
BMC Complement Med Ther. 2023; 23(1):128.
PMID: 37081536
PMC: 10116837.
DOI: 10.1186/s12906-023-03960-7.
Molecular Modes of Action of an Aqueous Extract in Cancer Cells In Vitro and In Vivo.
Rashan L, Ozenver N, Boulos J, Dawood M, Roos W, Franke K
Molecules. 2023; 28(4).
PMID: 36838857
PMC: 9960564.
DOI: 10.3390/molecules28041871.
Dual targets of lethal apoptosis and protective autophagy in liver cancer with periplocymarin elicit a limited therapeutic effect.
Hao Y, Song T, Wang M, Li T, Zhao C, Li T
Int J Oncol. 2023; 62(3).
PMID: 36825592
PMC: 9946806.
DOI: 10.3892/ijo.2023.5492.
Na, K-ATPase α1 cooperates with its endogenous ligand to reprogram immune microenvironment of lung carcinoma and promotes immune escape.
Yang K, Li Z, Yin F, Ji X, Zhou J, Li X
Sci Adv. 2023; 9(6):eade5393.
PMID: 36763655
PMC: 9916986.
DOI: 10.1126/sciadv.ade5393.
The botanical drug PBI-05204, a supercritical CO extract of , sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy and .
Vaccaro S, Rossetti A, Porrazzo A, Camero S, Cassandri M, Pomella S
Front Pharmacol. 2022; 13:1071176.
PMID: 36532747
PMC: 9751381.
DOI: 10.3389/fphar.2022.1071176.
Research progress in inducing immunogenic cell death of tumor cells.
Xie D, Wang Q, Wu G
Front Immunol. 2022; 13:1017400.
PMID: 36466838
PMC: 9712455.
DOI: 10.3389/fimmu.2022.1017400.
Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death.
Semba M, Takamatsu S, Komazawa-Sakon S, Miyoshi E, Nishiyama C, Nakano H
Int J Mol Sci. 2022; 23(13).
PMID: 35805980
PMC: 9266755.
DOI: 10.3390/ijms23136973.